adminの記事一覧

NGAL, L-FABP, and KIM-1 in comparison to established markers of renal dysfunction.

Clin Chem Lab Med. 52(4): 537-546, 2014.PubMed

Human liver-type fatty acid-binding protein protects against tubulointerstitial injury in aldosterone-induced renal injury.

Am J Physiol Renal Physiol. 308(2): F114-121, 2014.PubMed

Early prediction of acute kidney injury biomarkers after endovascular stent graft repair of aortic aneurysm: a prospective observational study.

J Intensive Care. 2(45), 2014.PubMed

Urinary liver-type fatty acid-binding protein linked with increased risk of acute kidney injury after allogeneic stem cell transplantation.

Biol Blood Marrow Transplant. 20(12): 2010-2014, 2014.PubMed

A newly developed kit for the measurement of urinary liver-type fatty acid-binding protein as a biomarker for acute kidney injury in patients with critical care.

J Infect Chemother. 21(3): 165-169, 2014.PubMed

Urinary biomarkers of kidney injury are associated with all-cause mortality in the Women’s Interagency HIV Study (WIHS).

HIV Med. 15(5): 291-300, 2014.PubMed

Urinary L-FABP predicts poor outcomes in critically ill patients with early acute kidney injury.

Kidney Int. 87(3): 640-648, 2014.PubMed

Level of urinary liver-type fatty acid-binding protein is associated with cardiac markers and electrocardiographic abnormalities in type-2 diabetes with chronic kidney disease stage G1 and G2.

Heart Vessels. 30(3): 362-368, 2014.PubMed

Nonalbuminuric proteinuria as a biomarker for tubular damage in early development of nephropathy with type 2 diabetic patients.

Diabetes Metab Res Rev. 30(8): 736-741, 2014.PubMed

Urine liver-type fatty acid-binding protein and kidney injury molecule-1 in HIV-infected patients receiving combined antiretroviral treatment based on tenofovir.

AIDS Res Hum Retroviruses. 30(4): 363-369, 2014.PubMed